Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 12INDUSTRY 3OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 6Solid Tumor 4Mesothelioma 3Solid Tumors 2Pediatric Solid Tumors 2Advanced Solid Tumor 2Thymoma 1Stomach Neoplasms 1Solitary Fibrous Tumor, Pleural 1Solid Tumor, Adult 1Retinoblastoma 1Refractory Solid Tumors 1Pleural Effusion, Malignant 1Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm Metastasis 1Malignant Solid Tumor 1Lymphoma, Follicular 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoglobulin Light-chain Amyloidosis 1Heart Neoplasms 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Cholangiocarcinoma 1Childhood Solid Tumor 1Carcinoma, Hepatocellular 1

Interventions

Valproic Acid 1Hydralazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Refractory Solid Tumors × Other solid neoplasm × Clear all
NCT00404508 2006-11-28

A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid Tumors

National Institute of Cancerología

Phase 2 Completed
15 enrolled
Other solid neoplasm

Refractory Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡